The IRCM
Research
The Clinic
Studying at IRCM
Core facilities
Conferences
Careers
Molecular Immunology
Skip navigation links
Director
Projects
Publications
Contact us


Research unit director
Projects

Major areas of our research interests focus on the following:

1) The molecular mechanisms that control the intracellular signaling threshold at the post-translational level: We are particularly interested in understanding the role of the Cbl family of E3 ubiquitin ligases in establishing and maintaining immune tolerance; We are also investigating the function of adaptor molecule Grb2 and the protein kinase A (PKA) pathway in lymphocyte and dendritic cell development and function.

2) The role of microRNA (miRNA) in immune system development and differentiation: microRNAs are a group of newly identified small, noncoding RNAs that regulate gene expression mainly through repressing protein translation. Our research puts specific emphasis on the function of miRNAs in hematopoietic stem/progenitor cell function, as well as in hematopoietic malignancy and cancer stem cell biology.

3) Modulating intracellular signaling for autoimmune and tumor immunotherapy: Our lab has previously identified E3 ubiquitin ligase Cbl-b as an important negative regulator for anti-tumor immunity. We are currently engaged in translational research to explore whether we can use this pathway as a target for cancer immunotherapy. Additionally, we have identified the PKA pathway as an important regulator for DC mediated homeostasis of regulatory T cells (Treg), an important T cell subset required for the maintenance of immune tolerance. We are now in the process of developing a strategy to modulate the PKA pathway in DCs and explore whether we can use this approach to treat autoimmune diseases such as type 1 diabetes (T1D) and systemic lupus erythematosis (SLE).

All rights reserved: IRCM 2011_110 avenue des Pins Ouest - Montréal (Québec) H2W 1R7 – Canada
.